May 21, 2022

Volume XII, Number 141

Advertisement
Advertisement

May 20, 2022

Subscribe to Latest Legal News and Analysis

May 19, 2022

Subscribe to Latest Legal News and Analysis

May 18, 2022

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
20
May
EU Seeks Input on Policy for Plants Developed Using New Genomic Techniques ArentFox Schiff LLP
20
May
The VALID Act: Senate Action Brings FDA Regulation of LDTs Closer to Fruition Epstein Becker & Green, P.C.
20
May
Recent FDA Enforcement Action Colors Regulatory Landscape for Delta-8 THC Products Epstein Becker & Green, P.C.
20
May
Implications of the Use of the Defense Production Act in the U.S. Supply Chain Bradley Arant Boult Cummings LLP
19
May
FDA Updates Agricultural Water Protocol Keller and Heckman LLP
19
May
Expert Witness Case Complexity & Vetting – Episode 36 [Podcast] IMS Consulting & Expert Services
19
May
FDA White Paper Signals Shift to Performance-Based Reviews of Mature Quality Systems Sheppard, Mullin, Richter & Hampton LLP
18
May
France Asks Providers to Give Updated R-Nano Declaration Numbers to Customers upon Request Bergeson & Campbell, P.C.
18
May
BridgeBio Transaction Reflects Healthy Market for FDA Priority Review Vouchers Proskauer Rose LLP
18
May
FDA Issued Enforcement Discretion Measures for Infant Formula Squire Patton Boggs (US) LLP
18
May
House Bill To Give FDA More Funding to Address Formula Shortage Keller and Heckman LLP
17
May
Episode 21: Putting People First in Behavioral Health Reform [PODCAST] Foley & Lardner LLP
17
May
FDA Releases Guidance on Infant Formula Enforcement Discretion Policy Keller and Heckman LLP
17
May
California Cannabis Farmers May Finally Get Some Relief Sheppard, Mullin, Richter & Hampton LLP
16
May
FDA Finalizes Guidance on Reducing Microbial Hazards in Seed for Sprouting Keller and Heckman LLP
13
May
FDA Expresses Displeasure with Consumer Products Containing Trendy Cannabis Ingredient Delta-8 THC Mintz
13
May
A New(ish) Chemical Excise Tax Effective July 2022 Proskauer Rose LLP
13
May
'Fresh, Local, Quality' — How Unverifiable Opinions Evade False Advertising Claims Katten
12
May
FDA Works to Improve Supply of Formula Products Keller and Heckman LLP
12
May
Recall Roundup: April 2022 Hunton Andrews Kurth

Pages